The c-fos protooncogene is transcriptionaily activated by a wide variety of agents including serum, growth factors, and phorbol esters. This induction is rapid and transient and is mediated through a number of identified promoter elements. Growth hormone (GH) is also known to induce transcription of c-fos in a variety of cell tpes including NIH 3T3 fibroblasts and 3T3-F442A preadipocytes. To identify DNA sequences in the c-fos gene regulated by GH, this study sought to determine whether induction of c-fos by GH involves previously identified c-fos promoter elements. A plasmid containing a growth factor-sensitive fragment of the upstream region of the c-fos promoter from -361 to -264 bp was tested for GH sensitivity. The fragment was cloned upstream of a human c-fos reporter [designated FOS by Human Gene Mapping 11 (1991)] , which included basal promoter elements. In transiently transfected mouse NIB 3T3 fibroblasts, the promoter fragment conferred GH sensitivity on the human c-fos reporter. To identify a specific GH-sensitive DNA sequence in this promoter, a serum response element (SRE)-reporter plasmid was tested and found to be stimulated by GH. GH was effective in inducing expression through the SRE over a range of physiological GH concentrations. Since GH was recently found to synergize with serum factors in inducing c-fos transcription, the effect of GH and serum on SRE function was examined for insight into the mechanism for such synergism. The combined effect of GH and serum to induce reporter expression through the SRE was greater than the added effects of GH and serum, indicating that the synergism between GH and serum in inducing c-fos involves the SRE sequence. These studies identify the SRE as one specific DNA sequence in the c-fos promoter functionally regulated by GH. It is notable that GH is effective at physiological concentrations. Furthermore, synergism in c-fos induction between GH and serum factors is evident through the SRE.
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Molecular events associated with the effects of growth hormone (GH) are just beginning to be elucidated. Among these events, GH rapidly and transiently increases expression of the protooncogene c-fos in a variety of cell types, including 3T3-F442A cells and NIH 3T3 fibroblasts (1) (2) (3) (4) (5) . The gene product Fos has been implicated as a transcription factor that regulates genes important in cell growth and differentiation (6, 7) . Hence, c-fos may play a focal role early in GH signaling and participate in the growth-promoting actions of GH.
At present, a DNA sequence in the c-fos promoter which is responsive to GH has not been identified. To determine whether a GH-responsive sequence could be identified within the c-fos promoter, this study examined the ability of GH to stimulate c-fos promoter-reporter plasmids. Since mechanis-
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tic features of the action of GH, a "classical" growthpromoting hormone, are reminiscent of the actions of other growth factors, the focus of this study included sequences from -350 to -295 bp upstream ofthe transcription start site, in which at least three regions have been identified that are responsive to growth factors. The serum response element (SRE; also called dyad symmetry element, DSE) mediates transcriptional stimulation by serum and a variety of growth factors (8) (9) (10) (11) . Other sites in this region include an AP-1 site immediately 3' of the SRE (12) and a region known as the SIF element, which lies 5' of the SRE and binds a factor inducible specifically by sis/platelet-derived growth factor in BALB/c 3T3 cells and by epidermal growth factor in A431 cells (13) (14) (15) ).
An appealing aspect of studying the induction of c-fos by GH in fibroblasts is that it occurs at GH concentrations in the physiological range. Hence, this study provides a context not only in which to identify a DNA sequence responsive to GH but in which to evaluate the role of such a sequence in GH action and to identify such functions in cells regulated by physiological levels of a major growth-promoting hormone.
MATERIALS AND METHODS
Plasmids. The plasmid 222FOS, containing the entire human c-fos transcription unit and 222 bp of promoter sequence, and the plasmid PB4/222 (F4K1), containing the sequence from -361 to -264 (13) upstream of 222FOS, have been described (14) . The plasmid DSE/222 (KB/KX) contains a SRE/DSE oligonucleotide in the indirect orientation (sequence, 5'-CAGATGTCCTAATATGGACATCCTCT-AG-3') upstream of 222FOS, as described (14) . The plasmid MSRE contains in the indirect orientation one copy of a mutated SRE which fails to bind the serum response factor (16 (1) or by the acid/phenol method (19) for Northern blot analysis. The Northern blot (1) and RNase protection (14) analyses were performed essentially as described. For RNase protection, RNA (30-40 ug) was denatured and incubated with RNA probes for c-fos and a-globin (200,000 cpm each) overnight at 55°C. The plasmids AHfos and SP6-a-globin used to generate RNA probes for analysis by RNase protection have been described (14, 18) . Digestion with RNase A (40 ,g/ml) and RNase Ti (2 .g/ml) for 1 h was followed by the addition of proteinase K. Double-stranded RNA products were precipitated, resuspended in loading buffer, and denatured at 80°C for 5 min. Samples were subjected to electrophoresis on a 6% polyacrylamide/urea gel; gels were dried and used in autoradiography. The estimated sizes of the transcripts studied were 280 nt for human c-fos, verified by running HeLa cell RNA on each gel as a reference, 125 nt for the a-globin control, and 65 nt for the endogenous mouse c-fos. Autoradiograms exposed in a linear range were quantified by laser-scanning densitometry and c-fos signals were normalized to those of the control probe.
RESULTS

A Growth Factor-Sensitive Fragment of the c-fos Promoter
Mediates a Response to GH. To elucidate the mechanism for transcriptional stimulation of c-fos by GH, a growth factorsensitive fragment ofthe human c-fos promoter was analyzed for its ability to confer responsiveness to GH. The fragment of the c-fos promoter (14) derived from the sequence -361 to -264 bp, containing the SRE and the flanking SIF element and AP-1 site, upstream of the human c-fos reporter gene 222FOS (diagrammed in Fig. 1 ) was found to be responsive to GH.
GH stimulated the expression of the human c-fos reporter through the -361 to -264 promoter fragment in mouse NIH 3T3 fibroblasts transiently transfected with the plasmid PB4/ (1) . This suggested that the DNA sequence from -361 to -264 in the human c-fos promoter confers sensitivity to GH in this system.
The SRE Mediates Induction of c-fos by GH. Since the -361 to -264 promoter fragment contains the SRE, which is highly responsive to growth factors, the effect of GH was tested by using a plasmid containing the SRE alone. The plasmid DSE/222 contains an oligonucleotide containing the se- (Fig. 2C) . Neither GH (lane C) nor serum (lane D) induced expression of the reporter driven by the mutated SRE (upper arrow), although the endogenous c-fos was stimulated by GH and serum (lower arrow). Taken together, these data indicate that the GH-sensitive region of the c-fos promoter is not present in the basal elements of 222FOS and resides in the SRE. Physiological Concentrations of GH Regulate c-fos Through the SRE. While previous studies have shown that the SRE responds to a variety of growth factors and some hormones, these agents have been tested at high concentrations and/or in cells overexpressing receptors (e.g., see ref. 10 ). In contrast, in the experiments shown above, the NIH 3T3 cells responded to GH at a concentration of 500 ng/ml, which is in the physiological range for GH secretory episodes in rodents (20, 21) . To determine whether GH was effective at even lower concentrations, the sensitivity of the SRE-reporter plasmid was tested at concentrations of GH ranging from 50 to 500 ng/ml. Fig. 3 (lanes B-E) shows that the SRE mediates human c-fos induction at a GH concentration as low as 50 ng/ml (lane C, upper arrow). Concentrations of GH from 50 to 1000 ng/ml increasingly stimulated the transfected human c-fos and the endogenous mouse c-fos in the same cells (lanes C-E; data not shown). This is especially impressive since NIH 3T3 cells are at least 10 times less sensitive to GH than other cells in which GH induces c-fos (2) .
The SRE Participates in Synergism Between GH and Serum. One recently identified feature of GH action is its synergism with serum factors in inducing -c-fos transcription in 3T3-F442A fibroblasts (22) . It is thought that synergism of GH with other growth factors might be an important component of the physiological effects of GH. To determine whether the synergism between GH and serum might occur in cells other than the highly sensitive 3T3-F442A fibroblasts, the combined effect of GH and serum was examined in the NIH 3T3 cells. Northern blot analysis indicates that synergism between GH and serum in inducing c-fos expression is evident in the NIH 3T3 cells (Fig. 4) . GH alone elicited a modest induction of c-fos when tested at 500 ng/ml (lane B). When the GH was added in combination with 1% calf serum (lane D), the induction of c-fos was greater than the added individual effects of GH and 1% calf serum, indicating that synergism between GH and serum occurred in the NIH 3T3 fibroblasts.
To determine whether synergism in induction of c-fos involved the SRE, the SRE-driven reporter plasmid (DSE/ 222) was tested for its ability to respond synergistically to GH and serum in the NIH 3T3 cells. Under the conditions ofthese experiments, cells are deprived of serum by using DMEM containing 1% bovine serum albumin, and subsequent incubation with low concentrations of calf serum elicits a modest stimulation of c-fos (Fig. 3, lane F; Fig. 4, lane C) . However, the combined effect of GH and 0.5% serum in inducing c-fos through the SRE, adjusted for transfection efficiency, was -2-fold greater than the sum of their individual effects (Fig.  3, lanes F-I) . This suggests that the SRE mediates at least part of the synergism between GH and other serum growth factors in increasing c-fos expression.
DISCUSSION
Analysis of the induction of c-fos transcription by GH facilitated identification of the c-fos SRE as a DNA sequence whose function is regulated by GH. The SRE/DSE was the first regulatory region identified in the c-fos promoter (8, 23, 24) and has been shown to mediate stimulation of c-fos not only by serum but also by a variety of agents including epidermal growth factor, nerve growth factor, plateletderived growth factor, insulin, and phorbol esters (9-11, 25, 26) .
In regulating SRE function, GH is effective at concentrations in the physiological range. This suggests that the induction of c-fos by GH can contribute to regulation by GH of normal cell growth and differentiation. This possibility is strengthened by observations that GH is a major factor required for the differentiation of 3T3-F442A preadipocytes to adipocytes (27, 28) , that GH stimulates c-fos transcription in 3T3-F442A cells (1) , and that Fos protein, in conjunction with Jun, regulates transcription of the differentiationdependent gene for adipocyte P2, a lipid binding protein, in 3T3-F442A cells (5, 6) .
The binding of nuclear proteins to the SRE is evident in nuclear extracts from both GH-treated and untreated NIH 3T3 or 3T3-F442A fibroblasts, as evaluated by electrophoretic mobility shift assay (D.J.M. and J.S., unpublished observations). This is not surprising, since the serum response factor is reported to be constitutively bound to the SRE and cannot be regulated by growth factors in most of the systems tested so far (15, 25) .
The SRE is quite distinct from a DNA sequence in the hepatic gene Spi-2.1, which has been shown to confer responsiveness to GH (29) . A 45-bp sequence in the 5' flanking region of this gene, which encodes a serine protease inhibitor, confers GH responsiveness on a heterologous promoter and reporter gene in hepatocytes when linked in tandem copies. This sequence showed no homology to the documented (GenBank data base) sequence for the human c-fos gene. The difference in these two GH responsive DNA sequences suggests that GH may regulate gene expression by multiple mechanisms.
The mechanism by which GH induces c-fos through the SRE is as yet unknown. It is unlikely that this response to GH is mediated by insulin-like growth factor 1 (IGF-1), since the induction of c-fos by GH is evident in <30 min, well before the induction of IGF-1 gene expression by GH (3) . The SRE appears to mediate c-fos transcription by protein kinase C-dependent and protein kinase C-independent pathways (26) . Since the induction of c-fos expression by GH has been reported to involve protein kinase C-dependent events in a variety of cell types (1, (3) (4) (5) , protein kinase C-dependent events may participate in the response of the SRE to GH.
Signaling mechanisms involved in responsiveness of the SRE to GH may be related to those for other members of the GH/cytokine/hematopoietic receptor superfamily, since ligands for at least three other members ofthis receptor family, interleukin 2 (IL-2), IL-3, and erythropoietin, also stimulate c-fos via the SRE in lymphoid cells (30) . Recent studies indicate that at least some of these receptor family members, including receptors for GH (31-33), IL-2 (34), and erythropoietin (35) , when activated by ligand, stimulate tyrosyl phosphorylation of their receptors and other cellular proteins. In addition, formation of complexes with cellular tyrosine kinases by the GH receptor, the IL-2 receptor, the prolactin receptor, and the erythropoietin receptor has been demonstrated (31) (32) (33) (34) (35) (36) . The kinase associated with the IL-2 receptor has been identified as p56lck (34) . Thus, it is tempting to speculate that tyrosine kinase-mediated events may participate in the mechanism by which GH regulates c-fos through the SRE. At least some of the multiple transcription factors that have been shown to associate with the SRE (8), including serum response factor and the ternary complex factor p62TCF, are known to be phosphorylated, and kinases such as casein kinase II and microtubule-associated protein kinase (MAP kinase) appear to be involved (37) (38) (39) . In this regard, it is of interest that GH has been shown to activate MAP kinase activity and to promote tyrosyl phosphorylation of MAP kinases in 3T3-F442A cells (40, 41) .
The present findings do not preclude the possibility that other sequences in the c-fos promoter also participate in mediating a response to GH. The present data indicate that GH does not induce c-fos through the basal sequences between -222 and the transcription start site. The possibility that other sequences are involved is strengthened by preliminary observations that GH induces SIF binding activity in nuclear extracts from 3T3-F442A cells (D.J.M., C. Hoban, B.H.C., and J.S., unpublished observation), suggesting a role for the SIF binding sequence in mediating a GH response. Furthermore, GH induced AP-1 binding activity in nuclear extracts from osteoblasts (4), suggesting involvement of AP-1 sites in response to GH. Whether such sequences participate in induction of c-fos by GH, whether they cooperate with each other and, indeed, whether they also contribute to synergism between GH and other growth factors remains to be determined. The mediation of the GH response by the SRE may thus be only one aspect of a more complex regulatory mechanism still to be elucidated.
